The Delta and Kappa variants of SARS-CoV-2 co-emerged in India in late 2020, with the…
pthomsonFebruary 11, 2022
For the second year in a row, the Paul G. Allen Frontiers Group has honoured…
pthomsonFebruary 10, 2022
Vancouver-based Canexia Health Inc. is merging with Imagia Cybernetics Inc. in a deal expected to…
pthomsonFebruary 10, 2022
Screening of a marine derived crude natural product extract library, followed by bioactivity guided fractionation, has led…
pthomsonFebruary 10, 2022
Vancouver – B.C. scientists published new research today in JAMA Network Open showing that removing a person’s fallopian tubes…
pthomsonFebruary 10, 2022
The CIHR Fall 2021 competition has approved 417 research grants and one bridge grant, for…
pthomsonFebruary 9, 2022
Six principal investigators within the LSI received funding via five grants from the Canadian Institutes…
pthomsonFebruary 9, 2022
Orkla Food Ingredients has inked a deal with Canada's Renaissance BioScience to exclusively produce and…
sciencecityJune 6, 2017
To mark Canada’s 150th birthday, we are counting down to Canada Day with profiles of…
sciencecityJune 5, 2017
Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) designed to “reboot” the…
sciencecityJune 1, 2017
A clinical trial for a type of brain stimulation therapy is underway at Surrey Memorial…
sciencecityMay 30, 2017
New medicines are no longer one-size-fits-all. Therapies are more complex, manufactured in smaller batches and…
sciencecityMay 29, 2017
“Think of a multiple sclerosis lesion as the tip of the iceberg,” says Dr. Alex…
sciencecityMay 26, 2017
In one of the most comprehensive studies to date, UBC researchers have identified potential adverse…
sciencecityMay 25, 2017
Researchers investigating genetically predisposed or at-risk individuals and their families affected by early onset cardiovascular…
sciencecityMay 24, 2017
